Vnitr Lek 2025, 71(8):E22-E27
Suspected pellagra in a patient treated with azathioprine for Crohn's disease
- 1 Hematologicko-transfúzní oddělení, Nemocnice AGEL Prostějov
- 2 AGEL Transfúzní služba, a.s.
- 3 Oddělení laboratorní medicíny, Nemocnice AGEL Prostějov
- 4 Interní oddělení, Nemocnice AGEL Prostějov
- 5 Laboratoře AGEL, a.s., Nový Jičín
Pellagra is a disease due to nutritional deficiency of niacin (vitamin B3). The main causes include nutritionally poor diet or impaired intestinal absorbtion. Other risk factors represent alcohol abuse, idiopathic bowel disease and immunosuppressive and antituberculotic treatment. Dermatitis, diarrhoea and dementia (3D) are characteristical clinical signs, untreated disease may lead to the death. The diagnosis is based on typical clinical signs which subside quickly after niacin supplementation. The authors present a clinical case of a patient with Crohn´s disease treated with azathioprine, who was acutely hospitalized for community-onset pneumonia, pancytopenia and symetrical sharply bordered maculous erythematous limb exanthema - clinically suspected of pellagra. The exanthema subsided completely within a week of parenteral niacin supplementation. Bone marrow examination led to the diagnosis of myelodysplastic neoplasia with low-blasts (MDS-LB). Niacin deficiency may have potentiated genotoxic effects of azathioprine. The patient was referred to the specialized hematooncological center.
Keywords: azathioprine, Crohn's disease, myelodysplastic syndrome, pellagra.
Accepted: November 26, 2025; Published: December 15, 2025 Show citation
References
- Hałubiec P, Leończyk M, Staszewski F, et al. Pathophysiology and clinical management of pellagra - a review. Folia Med Cracov. 2021; 61:125-137. doi: 10.24425/fmc.2021.138956.
Go to original source...
Go to PubMed... - Prabhu D, Dawe RS, Mponda K. Pellagra a review exploring causes and mechanisms, including isoniazid- induced pellagra. Photodermatol Photoimmunol Photomed. 2021; 37:99-104. doi: 10.1111/phpp.12659.
Go to original source...
Go to PubMed... - Rivadeneira A, Moyer P, Salciccioli JD. Pellagra in the USA: unusual manifestations of a rare entity. BMJ Case Rep. 2019; 12:e230972. doi:10.113/bcr-2019-230972.
Go to original source... - Mugabe VA, Mahumane A, Baltazar CS, et al. Cyclone Idai as a trigger for pellagra outbreak in Nhamatanda, Mozambique: A case control study. Am J Trop Med Hyg. 2021; 104(6):2233-2237. doi:10.4269/ajtmh.20-1321.
Go to original source...
Go to PubMed... - Portale S, Sculati M, Stanford FC, et al. Pellagra and anorexia nervosa: a case report. Eat Weight Disord. 2020; 25(5):1493-1496. doi:10.1007/s40519-019-00781-x.
Go to original source...
Go to PubMed... - Madhyastha SP, Shetty GV, Shetty VM, et al. The classic pellagra dermatitis. BMJ Case Rep. 2020; 13:e239741. doi:10.1136/bcr-2020-239741.
Go to original source...
Go to PubMed... - Tew JC, Harrington L, Elsayed H, et al. Pellagra as a differential diagnosis in the confused patient on the acute medical unit. BMC Case Rep. 2022; 15:e249405. doi:10.1136/bcr-2022-249405.
Go to original source...
Go to PubMed... - Wang J, Yu J, Huang X. Pellagra and peripheral neuropathy secondary to tuberculosis treatment. QJM: An International Journal of Medicine. 2023; 696-698. https://doi.org/10.1093/qjmed/hcad077.
Go to original source...
Go to PubMed... - Filippi J, AI-Jaouni R, Wiroth JB, et al. Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm Bowel Dis. 2006; 12(3):185-191. doi: 10.1097/01.MIB.0000206541.15963.c3.PMID: 16534419.
Go to original source... - Hui R Ch-Y, Kuo K-L, Yang T-W. A rare skin complication associated with Crohn's disease. Dermatol Online J. 2021; 160(3):669-670. doi: 10.1053/j.gastro.2020. 09. 047
Go to original source... - Dastychová E. Pelagra jako důsledek parciální resekce žaludku a chronického ethylismu. Prakt Lék. 1986; 66(17):634-635.
- Daniš M, Turček M. Pelarga jako komplikácia nadužívania alkohólu. Alkoholismus a drogové závislosti. 2017; 52(4):183-192.
- Crouwel F, Buiter HJC, de Boer NK. The thiopurine tale: an unexpected journey. J Crohn's Colitis. 2022; 16:1177-1183. https://doi.org/10.1093/ecco-jcc/jjac004
Go to original source...
Go to PubMed... - Souhrn údajů o přípravku Imasup 50 mg. Sp. zn. sukls34300/2025. Available from: https://prehledy.sukl.cz/prehled_leciv.html#/leciva/0249258.
- Abtahi-Naeini B, Rajabi P, Dehghani S. Azathioprine-induced pellagra in a child with autoimmune hepatitis: a case report and literature review. Clin Case Rep. 2021; 9:e04975. doi: 10.1002/ccr3.4975.
Go to original source...
Go to PubMed... - Wroński K, Holecki MT, Boguszewska N, et al. Bone marrow aplasia and neutropenic fever following azathioprine dose escalation in a TPMT-deficient patient with Crohn's disease and psoriatic arthritis - a CARE-compliant case. Clin Pract. 2025; 15(114):1-9. https://doi.org/10.3390/clinpract15060114.
Go to original source...
Go to PubMed... - De Boer NKH, Mulder CJJ, van Bodegraven AA. Myelotoxicity and hepatotoxicity during azathioprine therapy. Neth J Med. 2005; 63(11):444-446.
- Dickson AL, Daniel LL, Zanussi J, et al. TPMT and NUDT15 variants predict discontinuation of azathioprine for myelotoxicity in patients with inflammatory disease: real-world clinical results. Clin Pharmacol Ther. 2022; 111(1):263-271. doi:10.1002/cpt.2428.
Go to original source...
Go to PubMed... - Tanaka Y, Saito Y. Importance of NUDT15 polymorphisms in thiopurine treatments. J Pers Med. 2021; 11(778):1-10. doi:10.330/jpm11080778.
Go to original source... - Hessels AC, Sanders JSF, van de Ven AAJM, et al. Azathioprine hypersensitivity syndrome in a cohort of antineutrophil cytoplasmic antibody-associated vasculitis patients. J Allergy Clin Immunol Pract. 2019; 7(3):1004-1009. doi:1.1016/j.jaip.2018. 10. 018.
Go to original source...
Go to PubMed...




